Evidence map›Paper›PMID 21097628›Full record

ArticleJournal of bacteriology2011

Promoter discrimination at class I MarA regulon promoters mediated by glutamic acid 89 of the MarA transcriptional activator of Escherichia coli.

Robert G Martin, Judah L Rosner

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of bacteriology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Targeting MarA N-terminal domain dynamics to prevent DNA binding.Protein science : a publication of the Protein Society · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Tetracycline Antibiotics and Resistance.Cold Spring Harbor perspectives in medicine · 2016
    Review
  7. Review
  8. Review
  9. Article
  10. Comparative genomics boosts target prediction for bacterial small RNAs.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. MarA, SoxS and Rob ofInternational journal of biotechnology for wellness industries · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert G MartinLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892-0560, USA. rgmartin@helix.nih.gov
Judah L Rosner
National Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Nonheritable Antibiotic ResistanceZIADK036003 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI ROSNER, JUDAH L · 2009 to 2016
$2.1M
Intramural NIH HHS
6 · The paper itself

Abstract

Three paralogous transcriptional activators MarA, SoxS, and Rob, activate > 40 Escherichia coli promoters. To understand why MarA does not activate certain promoters as strongly as SoxS, we compared MarA, MarA mutants, and SoxS for their abilities to activate 16 promoters and to bind their cognate marbox binding sites. Replacement of the MarA glutamic acid residue 89 with alanine greatly increased the marbox binding and activation of many class I promoters. Like cells constitutive for SoxS, cells expressing the MarA with the E89A mutation were more resistant to superoxides than those harboring WT MarA. The activities of several other E89 substitutions ranked as follows: E89A > E89G > E89V > WT > E89D. Increased binding and activation occurred only at class I promoters when the 12th base of the promoter's marbox (a position at which there is no known interaction between the marbox and MarA) was not a T residue. Furthermore, WT MarA binding to a synthetic marbox in vitro was enhanced when the phosphate group between positions 12 and 13 was eliminated on one strand. The results demonstrate that relatively minor changes in a single amino acid side chain (e.g., alanine to valine or glutamic acid to aspartic acid) can strongly influence activity despite any evidence that the side chain is involved in positive interactions with either DNA or RNA polymerase. We present a model which attributes the differences in binding and activation to the interference between the β- and γ-carbons of the amino acid at position 89 and the phosphate group between positions 12 and 13.

Indexed as

Gene Expression Regulation, BacterialPromoter Regions, GeneticRegulonAmino Acid SubstitutionArtificial Gene Fusionbeta-GalactosidaseBinding SitesDNA-Binding ProteinsElectrophoretic Mobility Shift AssayEscherichia coliEscherichia coli ProteinsGenes, ReporterGlutamic AcidModels, BiologicalMutant ProteinsMutation, Missensebeta-GalactosidaseDNA-Binding ProteinsEscherichia coli ProteinsGlutamic AcidMarA protein, E coliMutant ProteinsSoxS protein, E coliTrans-Activators

Identifiers

PMID21097628
PMCPMC3019838
OpenAlexW2120632425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.